Global patent landscape of programmed cell death 1: implications of the rapid expansion.


INTRODUCTION Inhibitors of programmed cell death 1 (PD-1) and its ligands are producing a paradigm shift in cancer treatment. The promising clinical outcomes and a multi-billion dollar market have prompted active research and development and resulted in relentless patent protection. However, the global patent landscape in this field remains unclear. Areas… (More)
DOI: 10.1080/13543776.2017.1378349